Article summary

Article focus
• Effective control of influenza requires not only efficacious vaccines and functioning health systems but also community awareness and willingness to use available vaccines.
• This protocol describes a case study of influenza vaccine uptake using a mixed-methods approach in urban and rural Pune, India.
Key messages
• It is important to consider social and cultural features of the population and health system, and cultural experience and ideas about influenza influence prior and anticipated uptake of influenza vaccines.
• This approach to health social science is relevant for other conditions in other countries.
Strengths and limitations of this study
• The study will examine a topic of broad significance -pandemic influenza preparedness -in a city of India and its rural surroundings most seriously affected by influenza H1N1 morbidity and mortality.
• Although local research in other settings is required for planning vaccine action, findings from this study are likely to be relevant for consideration in other areas of India and elsewhere, even if they are not directly applicable. prophylaxis in most countries. 1 Vaccines are considered valuable not only in influenza prevention but also in mitigating severity and impact of the disease. [2] [3] [4] The capacity for influenza vaccine deployment is a critical public health priority for pandemic influenza preparedness. 5 Seasonal influenza vaccination represents complementary interests for avoiding severe influenza and its complications. Approximately 50 industrialised countries and some others with recent rapid economic development offer influenza vaccination to nationally defined high-risk groups, including elderly people and individuals with cardiovascular, metabolic, renal or immune-suppressing conditions. Influenza vaccination in pregnancy is considered safe, and is recommended for pregnant women during the influenza season. 1 As seasonal virus and pandemic influenza viruses circulate concurrently in many countries, both vaccines are recommended for simultaneous vaccination in these countries. 6 7 Although recent assessment of the role of human vaccines for control of pandemic and seasonal influenza acknowledges the importance of community acceptance and popular ideas that discourage use of safe and effective vaccines, they focus on questions of production and distribution. 8 Production capacity is required, but it is not itself sufficient for effective policy. Lower than anticipated rates of influenza vaccine uptake throughout the world, especially among health workers and students in vaccine programmes responding to the 2009/2010 pandemic influenza, highlight the problem.
9-11
Population acceptance must therefore be recognised as a major determinant of vaccine effectiveness, and the social, cultural and economic determinants of population acceptance require study and consideration for effective policy and action.
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Influenza vaccination was acknowledged as the best preventive strategy to deal with a pandemic in the PPRP. However, as vaccine manufacture for a novel virus takes around six months, the vaccine would only be available for a second wave of the pandemic. In view of the potential limited vaccine supply, the plan identified priority recipients, namely, health workers, the elderly, infants, people with existing health problems, and those who were responsible for essential services. In the event of a pandemic, a National Immunization Programme would be invoked to vaccinate these priority groups, and if vaccine supply was sufficient, which was considered an "unlikely scenario", the entire population would be vaccinated. The plan also explicitly acknowledged that vaccine action for seasonal influenza was not a priority, but acknowledged that surveillance was needed.
As seasonal influenza is not considered a public health problem in India, a policy for seasonal influenza vaccination does not exist. The priority for such a policy would only be apparent if the morbidity and mortality from seasonal influenza is known. This needs to be done through an effective influenza surveillance network.
To ensure pandemic vaccine production capacity, the PPRP nevertheless indicated a national policy that included production of seasonal influenza vaccines, so that vaccine manufacturers would be able 
Research on influenza vaccine acceptance
Acceptance of seasonal influenza vaccines has been studied in various countries for the general population and for special groups, such as the elderly, students and health workers. [12] [13] [14] [15] [16] A recent study found that among 802 student respondents in Vellore, India, only 12.7% had been vaccinated in the 2009/2010 pandemic; virtually the same proportion (13.0%) indicated plans to be vaccinated in the future, and most (74.0%) said they probably or definitely would not be vaccinated. 17 Among other studies in India, a knowledge, attitudes and practices (KAP) study in Chandigarh showed that only 14% of paediatricians were aware of the level of the WHO pandemic alert in 2009. 18 A study of highschool students in Bareilly, Uttar Pradesh, during the pandemic found high levels of awareness and concern, including 97% using a mask for protection; girls were better aware of the role of medicines and vaccines than boys. 19 Kamate et al. found high levels of awareness of pandemic influenza in Udaipur, Rajasthan, but inadequate attention to prevention; vaccines were not considered. 20 Although the literature indicates the nature of interest and approach of various KAP studies in India, and some studies have considered self-reported reasons for use and non-use of the vaccine, careful study of social and cultural determinants of vaccine uptake or refusal by examining patterns of behaviour that respondents are not necessarily able to explain for themselves is required.
Consideration of patterns of behaviour (i.e. intention to be vaccinated and actual uptake) and sociocultural determinants need not, and should not, be limited to self-reported respondent accounts.
Just as the evidence base for risk and treatment of disease relies on study of epidemiological patterns, rather than anecdotal clinical reports, the evidence base for social and cultural determinants of behaviour should also be rooted in evidence based on study of how illness-, treatment-and vaccinerelated experience and meaning are related to behaviour, and with regard to our current interest, the acceptance and use of influenza vaccine. The approach and methods of cultural epidemiology have been developed to address such questions. Social and cultural concepts (e.g. patterns of distress, 
Pandemic influenza in India and Pune
After the WHO declared an influenza pandemic (level 6) on 11 June 2009, active surveillance was initiated in India to detect cases among persons returning from travel to influenza-affected countries.
Pune was a major focus of the pandemic in India. The first pandemic H1N1 case was detected in the city on 22 June 2009, and the first death, a 14-year-old schoolgirl, was reported on 3 August 2009 and sensationalised in the media. 21 Out of the 93 reported influenza deaths in Pune, 65 were urban and 28 from rural areas. All but eight urban and one of the rural deaths were from pandemic H1N1 infection. Mortality was approximately 1 in 11 confirmed hospitalised cases, and rural areas had higher rates of transmission and mortality.
By August 2010 press coverage estimated that the death toll had reached 300. 22 The epidemic was classified as a category 3 level of severity, a severe public health problem. 23 With publicity, awareness and increasing fear of pandemic influenza, vaccination was recommended by the Indian Medical Association, and vaccine demand intensified, acknowledging the value of both injectable and intranasal products. 24 Tabloids also raised questions about the safety of the intranasal vaccine in a report of a fatality of a man with respiratory symptoms who took the vaccine even though it was contraindicated. 25 In any event, the enthusiastic demand for the vaccine during the pandemic appears not to have been generalised throughout the country, nor sustained without equivocation in Pune.
Features of acceptance, demand and refusal require further attention in the interest of pandemic preparedness to ensure vaccine effectiveness and the validity of assumptions of the PPRP. Study 
Research objectives
This study will examine social, cultural and economic determinants of prior use and anticipated acceptance of influenza vaccines among urban and rural populations of Pune District, Maharashtra, India. The following are specific study objectives:
(a) To elucidate community experience, meaning and behaviour concerning pandemic and seasonal influenza, and awareness, preference and use of vaccines to prevent them. The study will clarify the nature, variety and distribution of illness explanatory models of influenza, perceived risk and consequences of pandemic and seasonal influenza in both urban and rural areas; 
Methods and analysis
Study setting
The study will proceed in both urban and rural areas of Pune district, which is situated in Western Maharashtra in the Sahyadri mountain range of the Western Ghats. The district has a population of approximately 7.2 million according to the 2001 census. The district headquarters is Pune city, which has a population of 4 million and is the second largest urban agglomeration in the state of Maharashtra after Mumbai. The incidence of seasonal influenza is higher, but not exclusively confined to the rainy and winter seasons (October to January). The city has been an area of recent rapid growth. 
Study groups
Research activities include study of community residents, clinicians and several groups of key informants.
Urban and rural community members. The sample of approximately 400 respondents in total will include adult male and female residents of the four community study sites (two urban and two rural), stratified by sex and age group. Key informants. The following five categories of key informants will be included in the study:
• Adult urban and rural community members with history of pandemic influenza;
• Adult urban and rural community members with and without history of H1N1 vaccination;
• Health personnel including clinicians, nurses, paraprofessionals, administrators and support staff working at NH and DMH;
• Reporters and personalities working in the print, television and radio media who were involved in reporting on the H1N1 pandemic;
• Policy makers at district and state government levels.
Study design
Research activities will include urban and rural community surveys and in-depth interviews, clinician key-informant interviews, case studies at the two hospitals (DMH and NH) where many pandemic influenza case suspects were referred and in-depth interviews with media professionals and public health policy makers.
Community study
The community research will include three successive activities: formative ethnographic research, a cultural epidemiological survey and in-depth interviews with three sets of community respondents (i.e. respondents with a history of pandemic influenza and respondents with a history of H1N1 vaccination and non-vaccination). Qualitative research will proceed with focus group discussions (FGD) with community residents at the study sites. These FGDs clarify background features of the setting and sociocultural features of influenza and vaccine experience, which in turn will guide construction of interview questions and coding categories for the subsequent survey.
Cultural epidemiological survey with EMIC interview
A cultural epidemiological study design 28 will make use of ethnographic key informant interviews and focus group discussion data to develop explanatory model interviews based on the framework of the explanatory model interview catalogue (EMIC) for cultural epidemiology. 29 The data will include both qualitative narrative and coded categorical data indicating the distribution of features of the illness explanatory models and outcome variables concerned with vaccine acceptance. Although the approach is mostly closely related to OCV acceptance studies in Zanzibar, 26 Instrument. An explanatory model interview based on the EMIC framework will be adapted from the instruments used in the studies of oral cholera vaccine in Zanzibar, Kenya and DRC, based on illnessrelated, vaccine-specific and setting-specific features of the study. The structure of EMIC interview begins with questions about respondent characteristics. A sequence of two vignettes follows, depicting easily recognisable presentations of seasonal influenza and pandemic influenza. Each vignette is followed by a series of questions concerning recognition and cultural features of the condition (name, seriousness, course and outcome), perceived causes, treatment and prevention. The questions about pandemic influenza, however, are more extensive than questions about the seasonal influenza vignette, and they are followed by additional questions about prior and anticipated use of a vaccine if pandemic influenza were to recur, and vaccination priority for vulnerable members of the household. Pilot EMIC interviews will be prepared and tested in areas apart from the study site communities. 
Community case studies: pandemic influenza and H1N1 vaccination
In the third stage of the community study, in-depth interviews will follow the EMIC interview survey to elaborate experience of pandemic influenza and vaccine acceptance and non-acceptance, respectively. A subset of EMIC interview respondents with a history of pandemic influenza, with a history of H1N1 vaccination and those who did not take the H1N1 vaccine will be interviewed a second time as respondents for these community case studies. These will include identified cases of pandemic influenza (n=6-8: 3-4 urban and 3-4 rural, with equal sex ratio), H1N1 vaccination (n=6-8:
3-4 urban and 3-4 rural, with equal sex ratio) and H1N1 non-vaccination (n=6-8: 3-4 urban and 3-4 rural, with equal sex ratio). The recovery and vaccine-user vs. non-users perspectives will be elaborated in these interviews with an in-depth interview guide.
Clinician key informant interviews
Clinicians who were directly involved either in the clinical management of patients with pandemic influenza or in related public health pandemic H1N1 prevention activities will be requested to participate in key informant interviews. We will identify such key informant clinicians during earlier stages of the study from FGDs, EMIC interview data or with other respondent-based information that identifies clinicians engaged in relevant activities. These clinicians will be selected purposively, and the interview will be guided by a key informant agenda. and practicing in non-slum and slum areas (≥2 each) will be considered for the key informant interviews. In rural Pune, 4-6 clinicians who are working in community health centres or rural hospitals or block-level PHCs (≥2 each) and private practitioners in hospital and private practice settings (≥2 each) will be considered for the key informant interviews.
Hospital case studies
Dr. Naidu Hospital (NH) and Deenanath Mangeshkar Hospital (DMH) served as referral centres for treating cases of pandemic H1N1 influenza in Pune. In view of the large number of patients treated at each hospital, the experience acquired among clinicians working there and the authority conferred upon them by this experience, we will examine the experience of each as a case study. This will involve a series of interviews with administrators, clinicians and support staff, and a review of available records to clarify vaccine-related experience and activities during the pandemic, and in subsequent planning for pandemic and seasonal influenza preparedness. Data from community respondents treated at these centres, especially from in-depth interviews in the third phase of community study, will contribute to these hospital case studies. Approximately 5-10 interviews per institution will be undertaken. Secondary data from media reporting on the H1N1 pandemic will be compiled and analysed, and interviews will also be conducted with key-informant reporters and media personalities. These activities will clarify how the balance of public awareness, popular interest and public health priorities affects the interrelationship of media reporting and health system operations, with special consideration of NH and DMH, which were focal points of media reporting.
Policy review
Policy documents concerning pandemic preparedness and action plans, and influenza vaccine policy will be collected and analysed with reference to a framework for review and synthesis. As a follow-up activity to policy document analysis, key informant interviews with district and state government level policy makers will be conducted. Approximately 2-5 key informants will be interviewed at 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 A summary of the study components and methods, instruments and sampling is presented in table 1.
Data management and analysis
Data management
Quantitative data from EMIC interviews with general community members will be entered into a computer database in Epi Info.
Qualitative data from EMIC interviews, FGDs, key informant and in-depth interviews will be entered in a word processor and imported into MAXQDA, using appropriate techniques for automatic and manual coding.
Approach to analysis
The primary interest of the study will be to clarify descriptive, comparative and analytic accounts of explanatory models of influenza and how they explain awareness, acceptance and use of vaccines.
Comparative analysis will focus on questions of gender and rural-urban features of pandemic and seasonal influenza, and prior use and determinants of anticipated acceptance or refusal of influenza vaccines.
Quantitative analysis
Explanatory variables in this study would be social, cultural and economic features of illness experience, meaning and behaviour, and questions of awareness, preference and use of the intranasal vaccine for prevention of pandemic and seasonal influenza. Key questions concerned with explaining levels and determinants of acceptance will proceed with an initial bivariate analysis and logistic regression models for various levels of cost: fully subsidised (no charge); subsidised at 50% of cost which characterised periods of the pandemic in Pune.) Analysis will focus on the intranasal vaccine, and also consider it with reference to the injectable vaccine. Separate models will be analysed if differences appear substantial. Analysis of the determinants of acceptance will focus on pandemic influenza vaccine acceptance, but it will also consider seasonal influenza if a substantial enough percentage of respondents indicate acceptance.
Qualitative analysis
Notes and selective transcription of community-based FGD data will be entered in document groups of MAXQDA and thematically coded deductively with reference to the FGD agenda, which in turn is based on the structure of the EMIC interviews that the FGDs are intended to inform. Additional inductive coding will be employed as indicated to provide appropriate consideration of findings for which coding had not been anticipated.
EMIC interview data from community respondents will be imported into MAXQDA using the prestructured coding feature to automatically code narratives according to the structure of the semi- Key informant clinician interview data will be coded with reference to awareness, acceptance, personal use and prescribing patterns, which will be analysed accordingly.
Interview data and notes on relevant statistics from key hospitals of case studies will be thematically coded, enabling us to triangulate vaccine-related experience from alternative vantage points (hospital, Key informant policy maker data will be coded with reference to priorities of influenza vaccine preparedness for pandemic outbreaks, and for consideration of policy concerning seasonal influenza.
Ethics and dissemination
Ethics
The project protocol was approved by the institutional ethics committee of the Maharashtra Association of Anthropological Sciences, Pune, India, the World Health Organization Research Ethics
Review Committee, Geneva, Switzerland, and the Ethics Commission of Basel, Basel, Switzerland.
Confidentiality and anonymity for research participants will be strictly observed during the fieldwork and in subsequent publications. Written informed consent will be obtained prior to conducting interviews.
Dissemination and discussion
Findings from this study will be presented in scientific and public health conferences and published in international peer-reviewed journals. Feedback will be provided to public health officials at local and higher levels.
Experience and findings from this study will contribute to effective planning and implementation of a pandemic influenza vaccine strategy for India. Findings and the approach for health social science vaccine research will have implications and potential applications elsewhere for pandemic and seasonal influenza and for strategic planning of effective vaccine action for other vaccines as well.
The following are anticipated specific contributions of the research: Findings should thereby contribute to preparedness for a vaccine response to pandemic influenza, and guide strategic planning to address gaps and misunderstandings about the benefits and risks of influenza vaccines;
• Document level of awareness and acceptance of vaccines for seasonal influenza, indicating the potential value of influenza vaccines in India. Clarify the national priorities and potential market with reference to global interests in vaccine production for pandemic preparedness;
• Identify priorities and approaches for community action to contribute to health system preparedness for control of pandemic and seasonal influenza. Clarify current views of clinicians and other health professionals concerning both enthusiasm and reluctance to promote vaccine action for control of influenza;
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